Screening Breast MRI Primer: Indications, Current Protocols, and Emerging Techniques. Issue 3 (2nd April 2021)

• Record Type: Journal Article
• Authors: Samreen, Naziya; Mercado, Cecilia; Heacock, Laura; Chacko, Celin; Partridge, Savannah C; Chhor, Chloe
• Is Part Of: Journal of breast imaging. Volume 3:Issue 3(2021)
• Page Start: 387
• Page End: 398
• Publication Date: 2021-04-02
• Subjects: Breast MRI -- ultrafast MRI -- abbreviated breast MRI -- screening MRI; Breast -- Imaging -- Periodicals; Breast -- Cancer -- Diagnosis -- Periodicals; 616.994490
• DOI: 10.1093/jbi/wbaa116
• Languages: English
• ISSNs: 2631-6110

Abstract

Abstract: Breast dynamic contrast-enhanced MRI (DCE-MRI) is the most sensitive imaging modality for the detection of breast cancer. Screening MRI is currently performed predominantly in patients at high risk for breast cancer, but it could be of benefit in patients at intermediate risk for breast cancer and patients with dense breasts. Decreasing scan time and image interpretation time could increase cost-effectiveness, making screening MRI accessible to a larger group of patients. Abbreviated breast MRI (Ab-MRI) reduces scan time by decreasing the number of sequences obtained, but as multiple delayed contrast enhanced sequences are not obtained, no kinetic information is available. Ultrafast techniques rapidly acquire multiple sequences during the first minute of gadolinium contrast injection and provide information about both lesion morphology and vascular kinetics. Diffusion-weighted imaging is a noncontrast MRI technique with the potential to detect mammographically occult cancers. This review article aims to discuss the current indications of breast MRI as a screening tool, examine the standard breast DCE-MRI technique, and explore alternate screening MRI protocols, including Ab-MRI, ultrafast MRI, and noncontrast diffusion-weighted MRI, which can decrease scan time and interpretation time.